Loading...
Healthcare is the patient capital quadrant — and most founders forget the patient.
Scope: Clinical workflow, EHR integration, RCM, payer ops, ambient documentation, clinical trial tooling, patient-facing care, healthcare AI.
Cost-to-build
80/100
HIPAA, SOC 2, HL7 / FHIR integrations, and clinical-pilot overhead consistently pre-consume 18 months of runway.
Deal-velocity
46/100
Engineering acceleration in healthcare is a leading indicator with a longer fuse — 14–18 weeks rather than the cross-site median.
Live signal: 24 healthcare startups currently tracked for Q2 2026. See the roster →
Where Healthcare lands
Build
Build it yourself
Fund
Write the cheque
Avoid
Reroute the energy
Wait
Wait or partner
High cost-to-build, low deal-velocity. Capital-trap territory — stand down, partner with an incumbent, or stage cheques against milestones instead of announcements.
The honest version
Healthcare's velocity is below the cross-site median because procurement, compliance, and pilot cycles compress engineering signals into a much longer reveal window. The cost-to-build is dominated by compliance, integration, and clinical-evidence work that has no software-only shortcut. The quadrant is honest: this is wait-or-partner territory unless you already have clinical relationships.
If you are building
Fits when: You already work inside a clinical system or you are shipping a developer-tools-shaped layer that healthcare incidentally consumes.
If you are funding
Fits when: You can underwrite an 18–24 month pilot-to-revenue path and you have clinical references on the LP side.
Marginally. Ambient documentation and triage tooling shorten the signal-to-revenue path but still inherit the compliance cost-to-build. Treat them as healthcare with an AI/ML co-tag, not AI/ML with a healthcare lens.
Only adjacent — developer-tools-for-healthcare-engineering, MRV-style audit tooling, or pure infrastructure. Patient-facing scope without a clinical co-founder is rarely the right call.
Supply chain is the slowest-moving sector we track — bet on capital, not on velocity.
Robotics is the most capital-intensive sector — wait quadrant for almost everyone.
PropTech is the slowest fund-quadrant adjacent we track — avoid the indie path.
AgTech is hardware-heavy, slow, and only fundable inside a dedicated thesis.
Space tech is the only sector where the cheque needs nine zeros — wait quadrant for everyone else.
Every sector we track lives somewhere on the 2×2 — the index page groups all 20 verdicts in one place.
When the verdict isn’t enough
The free Monday email tells you which way the wind is blowing. If healthcareis the call you’re weighing this quarter, two faster moves: pull the live teardown on this one sector, or watch every sector week over week so you see the team pulling ahead before it shows up in someone’s deck.
Pressure-test one sector
€7
One sector, one teardown, one sitting. The same read your analyst would spend an afternoon on — who’s shipping like they’re about to raise, and who just looks busy. Cheaper than the coffee you’d buy to ask around.
Test one sector — €7 →Watch it move every week
€9.97/mo
The standing dashboard across every sector we track — so the team that quietly doubled overnight lands in front of you, not in front of the partner who beat you to the term sheet. The deck lags the work by 21 to 47 days; this is where you spend that head start.
Get the dashboard — €9.97/mo →